Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
about
Phase I study of fotemustine in pediatric patients with refractory brain tumors.Earlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients.Stem-cell transplant preparative regimens.Pharmacokinetics of high-dose chemotherapy.Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.The role of radiotherapy and chemotherapy in the treatment of primary adult high grade gliomas: assessment of patients for these treatment approaches and the common immediate side effects.High-dose etoposide: from phase I to a component of curative therapyAutologous bone marrow transplantation in pediatric solid tumors.Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review.Autologous marrow transplantation for Hodgkin's disease current techniques and prospects.Conditioning regimens in acute myeloid leukemia.The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of malignant lymphomas.Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging?A prospective randomized trial of central venous catheter removal versus intravenous amphotericin B in febrile neutropenic patients.Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells.Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.Acute myocardial ischemia after high-dose therapy with BEAM regimen.High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.Multiorgan failure associated with lomustine overdose.Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies
P2860
Q33344136-CBF86FED-7749-40C9-92AB-EA202B1415D0Q33781825-B339E39A-AF73-4E26-B149-89E021A1291CQ33788170-7D799B5A-1AA3-46A4-B1E0-7C4B24DB308DQ35597047-36382019-2A29-4497-B105-227A8BCC3459Q35847602-F1C03282-C317-4FDE-9027-45BCEEE78838Q36027181-9D596E52-0156-4867-86C7-9C0A61EB7B27Q36420106-5554F33C-E0C6-4F8E-A617-120109B3E65CQ36487745-C4F7086E-C3C7-46EF-AA5C-E5B21E8B059BQ37141576-618D2D8D-F8A3-42B9-8412-15B4D1B7367FQ37891766-E2D7B672-FEA4-4447-B90D-4A86BDED645BQ37920717-E842DCF9-3EC3-4578-B913-C8486592EE98Q37929981-56533B03-DCE3-4749-AC5E-5CB29EC7F1CFQ38229633-0D6AE01B-72D5-4BDF-ADE9-72D8D9B032DEQ39533043-BE35B764-62B2-49CE-A8F5-21B4D6B8EB9FQ39661825-351928BD-B8B3-450D-95B4-00616685A3B1Q40824528-3115575A-FB0F-41D8-933E-2229A75ACD0CQ43159277-F32BFA71-BFD6-47CA-9C79-C7FFE0B33CE4Q43246067-31B7558B-CB19-4D4C-8D59-4883AAF20024Q44119545-CB0F42E3-B944-4CF1-83E3-FA332093428BQ44789506-B9FFDBA5-46C7-4BE2-9868-B3CF228FA6BAQ55480934-1BFBA5B0-4A5D-4A20-B2BF-993A7BB05E47Q57786613-E5A2720F-EC97-4D0D-ADB4-5C43417FF2A1
P2860
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Intensive 1,3-bis(2-chloroethy ...... ry cancer. A phase I-II study.
@en
Intensive 1,3-bis(2-chloroethy ...... ry cancer. A phase I-II study.
@nl
type
label
Intensive 1,3-bis(2-chloroethy ...... ry cancer. A phase I-II study.
@en
Intensive 1,3-bis(2-chloroethy ...... ry cancer. A phase I-II study.
@nl
prefLabel
Intensive 1,3-bis(2-chloroethy ...... ry cancer. A phase I-II study.
@en
Intensive 1,3-bis(2-chloroethy ...... ry cancer. A phase I-II study.
@nl
P2093
P1433
P1476
Intensive 1,3-bis(2-chloroethy ...... ry cancer. A phase I-II study.
@en
P2093
B S Kramer
G L Phillips
G P Herzig
H M Lazarus
R H Herzig
R S Weiner
P304
P356
10.1002/1097-0142(19831115)52:10<1792::AID-CNCR2820521006>3.0.CO;2-D
P407
P577
1983-11-01T00:00:00Z